MicrobiologybioRxivPreprint
Subtherapeutic doses of vancomycin synergize with bacteriophages for treatment of experimental methicillin-resistant Staphylococcus aureus infective endocarditis
J. Save, Y.-A. Que, J. M. Entenza-Pousada, G. Resch
This study shows that combining subtherapeutic vancomycin with bacteriophages reduces MRSA bacterial load in experimental endocarditis.
DOI 10.1101/2022.06.02.494631